144 related articles for article (PubMed ID: 25964571)
1. Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil.
Silva TB; Oliveira CZ; Faria EF; Mauad EC; Syrjänen KJ; Carvalho AL
Anticancer Res; 2015 May; 35(5):2881-6. PubMed ID: 25964571
[TBL] [Abstract][Full Text] [Related]
2. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.
Chun FK; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Abbou CC; Stillebroer AB; van Gils MP; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Haese A
Eur Urol; 2009 Oct; 56(4):659-67. PubMed ID: 19304372
[TBL] [Abstract][Full Text] [Related]
5. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
6. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
7. A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.
Ouzaid I; Yates DR; Hupertan V; Mozer P; Chartier-Kastler E; Haertig A; Bitker MO; Rouprêt M
Prostate; 2012 Aug; 72(11):1200-6. PubMed ID: 22213470
[TBL] [Abstract][Full Text] [Related]
8. External validation of nomogram predicting the probability of specimen-confined disease (pT2-3a, R0N0) in patients undergoing radical prostatectomy and pelvic lymph node dissection.
Mearini L; Gacci M; Saleh O; De Nunzio C; Schiavina R; Simonato A; Tubaro A; Carmignani G; Mirone V; Carini M; Bini V; Porena M;
Urol Int; 2014; 93(3):262-8. PubMed ID: 24356093
[TBL] [Abstract][Full Text] [Related]
9. Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.
Lughezzani G; Lazzeri M; Larcher A; Lista G; Scattoni V; Cestari A; Buffi NM; Bini V; Guazzoni G
J Urol; 2012 Oct; 188(4):1144-50. PubMed ID: 22901589
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of an extended 10-core biopsy nomogram.
Chun FK; Briganti A; Graefen M; Montorsi F; Porter C; Scattoni V; Gallina A; Walz J; Haese A; Steuber T; Erbersdobler A; Schlomm T; Ahyai SA; Currlin E; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
Eur Urol; 2007 Aug; 52(2):436-44. PubMed ID: 17010505
[TBL] [Abstract][Full Text] [Related]
11. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
12. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
[TBL] [Abstract][Full Text] [Related]
13. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
[TBL] [Abstract][Full Text] [Related]
14. Predicting prostate biopsy outcome using a PCA3-based nomogram in a Polish cohort.
Salagierski M; Mulders P; Schalken JA
Anticancer Res; 2013 Feb; 33(2):553-7. PubMed ID: 23393348
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.
Rubio-Briones J; Borque A; Esteban LM; Casanova J; Fernandez-Serra A; Rubio L; Casanova-Salas I; Sanz G; Domínguez-Escrig J; Collado A; Gómez-Ferrer A; Iborra I; Ramírez-Backhaus M; Martínez F; Calatrava A; Lopez-Guerrero JA
BMC Cancer; 2015 Sep; 15():633. PubMed ID: 26362197
[TBL] [Abstract][Full Text] [Related]
16. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
Yanke BV; Gonen M; Scardino PT; Kattan MW
J Urol; 2005 Feb; 173(2):421-4. PubMed ID: 15643192
[TBL] [Abstract][Full Text] [Related]
17. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
18. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
[TBL] [Abstract][Full Text] [Related]
19. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
[TBL] [Abstract][Full Text] [Related]
20. A novel nomogram predicting the risk of positive biopsy for patients in the diagnostic gray area of prostate cancer.
Hou GD; Zheng Y; Zheng WX; Gao M; Zhang L; Hou NN; Yuan JR; Wei D; Ju DE; Dun XL; Wang FL; Yuan JL
Sci Rep; 2020 Oct; 10(1):17675. PubMed ID: 33077762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
